Literature DB >> 28303517

Vascular and perivascular niches, but not the osteoblastic niche, are numerically restored following allogeneic hematopoietic stem cell transplantation in patients with aplastic anemia.

Liangliang Wu1, Wenjian Mo1, Yuping Zhang1, Ming Zhou1, Yumiao Li1, Ruiqing Zhou1, Shiling Xu1, Shiyi Pan1, Hui Deng2, Ping Mao1, Shunqing Wang3.   

Abstract

Bone marrow (BM) niches, including the osteoblastic, vascular, and perivascular niches, are numerically impaired in patients with aplastic anemia (AA). It remains unclear whether these niches are numerically restored in AA patients after allogenic hematopoietic stem cell transplantation (allo-HSCT). To investigate changes in BM niches, we monitored 52 patients with AA who had undergone allo-HSCT and performed immunohistochemical studies of BM niches using antibodies against CD34, CD146, and osteopontin. After allo-HSCT, patients with AA exhibited a remarkable increase in the number of cellular elements in the BM niches, including the vascular and perivascular cells. However, no significant differences in endosteal cells were detected. We explored the cause of this restoration by analyzing the origin of BM mesenchymal stem cells (BM-MSCs) and the expression of cytokines in BM plasma. STR-PCR revealed that the BM-MSCs were derived from the host, not the donor. In addition, significantly elevated levels of vascular endothelial growth factor (VEGF) were found after allo-HSCT. Our data indicates that vascular and perivascular niches are numerically restored, but the endosteal niche remains numerically impaired in patients with AA after allo-HSCT, and that levels of VEGF, but not donor-derived BM-MSCs, may correlate with the restoration of BM niches.

Entities:  

Keywords:  Allo-HSCT; Aplastic anemia; Bone marrow niche

Mesh:

Substances:

Year:  2017        PMID: 28303517     DOI: 10.1007/s12185-017-2217-1

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  44 in total

1.  Osteoblast precursor cells are found in CD34+ cells from human bone marrow.

Authors:  J L Chen; P Hunt; M McElvain; T Black; S Kaufman; E S Choi
Journal:  Stem Cells       Date:  1997       Impact factor: 6.277

2.  Evaluation of the sensitivity of two recently developed STR multiplexes for the analysis of chimerism after haematopoietic stem cell transplantation.

Authors:  A Odriozola; J A Riancho; M Colorado; M T Zarrabeitia
Journal:  Int J Immunogenet       Date:  2012-05-18       Impact factor: 1.466

Review 3.  Making sense of hematopoietic stem cell niches.

Authors:  Philip E Boulais; Paul S Frenette
Journal:  Blood       Date:  2015-03-11       Impact factor: 22.113

4.  Mesenchymal stem cells are present in peripheral blood and can engraft after allogeneic hematopoietic stem cell transplantation.

Authors:  Eva María Villaron; Julia Almeida; Natalia López-Holgado; Miguel Alcoceba; Luis Ignacio Sánchez-Abarca; Fermin Martin Sanchez-Guijo; Mercedes Alberca; Jose Antonio Pérez-Simon; Jesus Fernando San Miguel; María Consuelo Del Cañizo
Journal:  Haematologica       Date:  2004-12       Impact factor: 9.941

5.  Evaluation of angiogenesis and vascular endothelial growth factor expression in the bone marrow of patients with aplastic anemia.

Authors:  Wolfgang Füreder; Maria-Theresa Krauth; Wolfgang R Sperr; Karoline Sonneck; Ingrid Simonitsch-Klupp; Leonhard Müllauer; Michael Willmann; Hans-Peter Horny; Peter Valent
Journal:  Am J Pathol       Date:  2006-01       Impact factor: 4.307

6.  Therapeutic potential of vasculogenesis and osteogenesis promoted by peripheral blood CD34-positive cells for functional bone healing.

Authors:  Tomoyuki Matsumoto; Atsuhiko Kawamoto; Ryosuke Kuroda; Masakazu Ishikawa; Yutaka Mifune; Hiroto Iwasaki; Masahiko Miwa; Miki Horii; Saeko Hayashi; Akira Oyamada; Hiromi Nishimura; Satoshi Murasawa; Minoru Doita; Masahiro Kurosaka; Takayuki Asahara
Journal:  Am J Pathol       Date:  2006-10       Impact factor: 4.307

7.  Current outcome of HLA identical sibling versus unrelated donor transplants in severe aplastic anemia: an EBMT analysis.

Authors:  Andrea Bacigalupo; Gerard Socié; Rose Marie Hamladji; Mahmoud Aljurf; Alexei Maschan; Slawomira Kyrcz-Krzemien; Alicja Cybicka; Henrik Sengelov; Ali Unal; Dietrich Beelen; Anna Locasciulli; Carlo Dufour; Jakob R Passweg; Rosi Oneto; Alessio Signori; Judith C W Marsh
Journal:  Haematologica       Date:  2015-01-23       Impact factor: 9.941

8.  Bone marrow mesenchymal stem cells from patients with aplastic anemia maintain functional and immune properties and do not contribute to the pathogenesis of the disease.

Authors:  Clara Bueno; Mar Roldan; Eduardo Anguita; Damia Romero-Moya; Beatriz Martín-Antonio; Michael Rosu-Myles; Consuelo del Cañizo; Francisco Campos; Regina García; Maite Gómez-Casares; Jose Luis Fuster; Manuel Jurado; Mario Delgado; Pablo Menendez
Journal:  Haematologica       Date:  2014-04-11       Impact factor: 9.941

9.  VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism.

Authors:  Hans-Peter Gerber; Ajay K Malik; Gregg P Solar; Daniel Sherman; Xiao Huan Liang; Gloria Meng; Kyu Hong; James C Marsters; Napoleone Ferrara
Journal:  Nature       Date:  2002-06-27       Impact factor: 49.962

10.  Endothelial and perivascular cells maintain haematopoietic stem cells.

Authors:  Lei Ding; Thomas L Saunders; Grigori Enikolopov; Sean J Morrison
Journal:  Nature       Date:  2012-01-25       Impact factor: 49.962

View more
  6 in total

Review 1.  Acquired Aplastic Anemia: What Have We Learned and What Is in the Horizon?

Authors:  Süreyya Savaşan
Journal:  Pediatr Clin North Am       Date:  2018-06       Impact factor: 3.278

2.  Outcome of allogeneic hematopoietic stem cell transplantation for hypoplastic myelodysplastic syndrome.

Authors:  Ming Zhou; Liangliang Wu; Yuping Zhang; Wenjian Mo; Yumiao Li; Xiaowei Chen; Caixia Wang; Shiyi Pan; Shilin Xu; Wei Zhou; Tingfen Deng; Shunqing Wang
Journal:  Int J Hematol       Date:  2020-08-16       Impact factor: 2.490

Review 3.  The Role and Mechanism of the Vascular Endothelial Niche in Diseases: A Review.

Authors:  Zhiqiang Lei; Xiang Hu; Yaoqi Wu; Longsheng Fu; Songqing Lai; Jing Lin; Xiaobing Li; Yanni Lv
Journal:  Front Physiol       Date:  2022-04-27       Impact factor: 4.755

4.  Bone Marrow Mesenchymal Stem Cells Carrying FANCD2 Mutation Differ from the Other Fanconi Anemia Complementation Groups in Terms of TGF-β1 Production.

Authors:  Ilgin Cagnan; Aysen Gunel-Ozcan; Fatima Aerts-Kaya; Najim Ameziane; Baris Kuskonmaz; Josephine Dorsman; Fatma Gumruk; Duygu Uckan
Journal:  Stem Cell Rev Rep       Date:  2018-06       Impact factor: 5.739

5.  Human Acquired Aplastic Anemia Patients' Bone-Marrow-Derived Mesenchymal Stem Cells Are Not Influenced by Hematopoietic Compartment and Maintain Stemness and Immune Properties.

Authors:  Vandana Sharma; Sonali Rawat; Suchi Gupta; Sweta Tamta; Rinkey Sharma; Tulika Seth; Sujata Mohanty
Journal:  Anemia       Date:  2021-04-29

Review 6.  Mesenchymal Stem Cells in Aplastic Anemia and Myelodysplastic Syndromes: The "Seed and Soil" Crosstalk.

Authors:  Bruno Fattizzo; Juri A Giannotta; Wilma Barcellini
Journal:  Int J Mol Sci       Date:  2020-07-30       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.